tiprankstipranks
Advertisement
Advertisement

DE:56F Stock Latest News

EXACT Therapeutics to Be Delisted from Euronext Growth Oslo in October 2026
Company AnnouncementsEXACT Therapeutics to Be Delisted from Euronext Growth Oslo in October 2026
1M ago
56F
EXACT Therapeutics wins safety green light to escalate PS101 dose in pancreatic cancer trial
PremiumCompany Announcements
EXACT Therapeutics wins safety green light to escalate PS101 dose in pancreatic cancer trial
1M ago
56F
EXACT Therapeutics Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
EXACT Therapeutics Shareholders Approve All Resolutions at 2026 AGM
2M ago
56F
EXACT Therapeutics plans webcast on proposed Euronext Growth delisting
PremiumCompany Announcements
EXACT Therapeutics plans webcast on proposed Euronext Growth delisting
2M ago
56F
EXACT Therapeutics Schedules Webcast on Proposed Euronext Growth Delisting
PremiumCompany Announcements
EXACT Therapeutics Schedules Webcast on Proposed Euronext Growth Delisting
2M ago
56F
EXACT Therapeutics Sets Virtual AGM as It Advances Ultrasound-Driven Oncology Platform
PremiumCompany AnnouncementsEXACT Therapeutics Sets Virtual AGM as It Advances Ultrasound-Driven Oncology Platform
2M ago
56F
EXACT Therapeutics Publishes 2025 Annual Report and Highlights PS101 Pipeline Progress
Premium
Company Announcements
EXACT Therapeutics Publishes 2025 Annual Report and Highlights PS101 Pipeline Progress
4M ago
56F
EXACT Therapeutics Registers Share Capital Increase After Warrant Exercise
Premium
Company Announcements
EXACT Therapeutics Registers Share Capital Increase After Warrant Exercise
4M ago
56F
EXACT Therapeutics Expands Share Capital After Warrant Exercise Approval
PremiumCompany Announcements
EXACT Therapeutics Expands Share Capital After Warrant Exercise Approval
5M ago
56F
EXACT Therapeutics Reaches Key Milestone in Pancreatic Cancer Phase 2 Trial
PremiumCompany Announcements
EXACT Therapeutics Reaches Key Milestone in Pancreatic Cancer Phase 2 Trial
5M ago
56F
EXACT Therapeutics Calls Extraordinary General Meeting to Approve Warrant-Related Share Issue
PremiumCompany Announcements
EXACT Therapeutics Calls Extraordinary General Meeting to Approve Warrant-Related Share Issue
5M ago
56F
EXACT Therapeutics Raises NOK 59.4 Million Through Warrant Exercises
PremiumCompany Announcements
EXACT Therapeutics Raises NOK 59.4 Million Through Warrant Exercises
5M ago
56F
EXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program
PremiumCompany AnnouncementsEXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program
6M ago
56F
EXACT Therapeutics Secures Major Warrant Exercise as GE HealthCare Unit Commits
Premium
Company Announcements
EXACT Therapeutics Secures Major Warrant Exercise as GE HealthCare Unit Commits
6M ago
56F
EXACT Therapeutics Corrects Final Exercise Date for Outstanding Warrants
Premium
Company Announcements
EXACT Therapeutics Corrects Final Exercise Date for Outstanding Warrants
6M ago
56F
EXACT Therapeutics Secures NOK 46 Million as Key Investors Exercise Warrants
PremiumCompany Announcements
EXACT Therapeutics Secures NOK 46 Million as Key Investors Exercise Warrants
6M ago
56F
GE Medical Holding Exercises Warrants in EXACT Therapeutics After Positive Pancreatic Cancer Trial Read-Out
PremiumCompany Announcements
GE Medical Holding Exercises Warrants in EXACT Therapeutics After Positive Pancreatic Cancer Trial Read-Out
6M ago
56F
EXACT Therapeutics Clears Key Safety Hurdle in Phase 2 Pancreatic Cancer Trial, Activating Potential Warrant Exercise
PremiumCompany Announcements
EXACT Therapeutics Clears Key Safety Hurdle in Phase 2 Pancreatic Cancer Trial, Activating Potential Warrant Exercise
6M ago
56F
EXACT Therapeutics Showcases Phase 2 Pancreatic Cancer Trial at ASCO GI 2026
PremiumCompany Announcements
EXACT Therapeutics Showcases Phase 2 Pancreatic Cancer Trial at ASCO GI 2026
7M ago
56F
EXACT Therapeutics to Present at Nordic Healthcare Conference
PremiumCompany AnnouncementsEXACT Therapeutics to Present at Nordic Healthcare Conference
8M ago
56F
EXACT Therapeutics Introduces New Incentive Program
Premium
Company Announcements
EXACT Therapeutics Introduces New Incentive Program
8M ago
56F
EXACT Therapeutics Releases Interim 2025 Results, Highlights Precision Health Advances
Premium
Company Announcements
EXACT Therapeutics Releases Interim 2025 Results, Highlights Precision Health Advances
10M ago
56F

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >